Breast cancer is clinically categorized into three primary subtypes: estrogen receptor/progesterone receptor (ER/PR)-positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer (TNBC). Here, ERBB2 is linked to triple-negative breast carcinoma.